Global Pharmaceutical Grade Poloxamers Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Poloxamers are nonionic triblock copolymers composed of a central hydrophobic chain of polyoxypropylene (poly(propylene oxide)) flanked by two hydrophilic chains of polyoxyethylene (poly(ethylene oxide)). As well known solubilizers, pharmaceutical grade poloxamers are primarily employed to enhance solubility, absorption, and bioavailability of low-solubility actives. In addition to functioning as solubilizers, poloxamers can also be used as wetting agents, lubricants, or emulsifiers.
The global Pharmaceutical Grade Poloxamers market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Pharmaceutical Grade Poloxamers Industry Forecast” looks at past sales and reviews total world Pharmaceutical Grade Poloxamers sales in 2023, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Grade Poloxamers sales for 2024 through 2030. With Pharmaceutical Grade Poloxamers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Grade Poloxamers industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Grade Poloxamers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Grade Poloxamers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Grade Poloxamers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Grade Poloxamers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Grade Poloxamers.
United States market for Pharmaceutical Grade Poloxamers is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Pharmaceutical Grade Poloxamers is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Pharmaceutical Grade Poloxamers is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Pharmaceutical Grade Poloxamers players cover BASF, Croda, Syensqo, Nanjing Well Pharmaceutical, Hubei Hengshuo Chemical, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Grade Poloxamers market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Pharmaceutical Grade Poloxamers market?
What factors are driving Pharmaceutical Grade Poloxamers market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Grade Poloxamers market opportunities vary by end market size?
How does Pharmaceutical Grade Poloxamers break out by Type, by Application?
Poloxamers are nonionic triblock copolymers composed of a central hydrophobic chain of polyoxypropylene (poly(propylene oxide)) flanked by two hydrophilic chains of polyoxyethylene (poly(ethylene oxide)). As well known solubilizers, pharmaceutical grade poloxamers are primarily employed to enhance solubility, absorption, and bioavailability of low-solubility actives. In addition to functioning as solubilizers, poloxamers can also be used as wetting agents, lubricants, or emulsifiers.
The global Pharmaceutical Grade Poloxamers market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Pharmaceutical Grade Poloxamers Industry Forecast” looks at past sales and reviews total world Pharmaceutical Grade Poloxamers sales in 2023, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Grade Poloxamers sales for 2024 through 2030. With Pharmaceutical Grade Poloxamers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Grade Poloxamers industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Grade Poloxamers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Grade Poloxamers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Grade Poloxamers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Grade Poloxamers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Grade Poloxamers.
United States market for Pharmaceutical Grade Poloxamers is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Pharmaceutical Grade Poloxamers is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Pharmaceutical Grade Poloxamers is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Pharmaceutical Grade Poloxamers players cover BASF, Croda, Syensqo, Nanjing Well Pharmaceutical, Hubei Hengshuo Chemical, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Grade Poloxamers market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Poloxamer 188
- Poloxamer 124
- Poloxamer 407
- Poloxamer 338
- Others
- Injectable Formulation
- Oral Formulation
- Topical Formulation
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BASF
- Croda
- Syensqo
- Nanjing Well Pharmaceutical
- Hubei Hengshuo Chemical
- CD Formulation
What is the 10-year outlook for the global Pharmaceutical Grade Poloxamers market?
What factors are driving Pharmaceutical Grade Poloxamers market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Grade Poloxamers market opportunities vary by end market size?
How does Pharmaceutical Grade Poloxamers break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical Grade Poloxamers Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Pharmaceutical Grade Poloxamers by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Pharmaceutical Grade Poloxamers by Country/Region, 2019, 2023 & 2030
2.2 Pharmaceutical Grade Poloxamers Segment by Type
2.2.1 Poloxamer
2.2.2 Poloxamer
2.2.3 Poloxamer
2.2.4 Poloxamer
2.2.5 Others
2.3 Pharmaceutical Grade Poloxamers Sales by Type
2.3.1 Global Pharmaceutical Grade Poloxamers Sales Market Share by Type (2019-2024)
2.3.2 Global Pharmaceutical Grade Poloxamers Revenue and Market Share by Type (2019-2024)
2.3.3 Global Pharmaceutical Grade Poloxamers Sale Price by Type (2019-2024)
2.4 Pharmaceutical Grade Poloxamers Segment by Application
2.4.1 Injectable Formulation
2.4.2 Oral Formulation
2.4.3 Topical Formulation
2.5 Pharmaceutical Grade Poloxamers Sales by Application
2.5.1 Global Pharmaceutical Grade Poloxamers Sale Market Share by Application (2019-2024)
2.5.2 Global Pharmaceutical Grade Poloxamers Revenue and Market Share by Application (2019-2024)
2.5.3 Global Pharmaceutical Grade Poloxamers Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Pharmaceutical Grade Poloxamers Breakdown Data by Company
3.1.1 Global Pharmaceutical Grade Poloxamers Annual Sales by Company (2019-2024)
3.1.2 Global Pharmaceutical Grade Poloxamers Sales Market Share by Company (2019-2024)
3.2 Global Pharmaceutical Grade Poloxamers Annual Revenue by Company (2019-2024)
3.2.1 Global Pharmaceutical Grade Poloxamers Revenue by Company (2019-2024)
3.2.2 Global Pharmaceutical Grade Poloxamers Revenue Market Share by Company (2019-2024)
3.3 Global Pharmaceutical Grade Poloxamers Sale Price by Company
3.4 Key Manufacturers Pharmaceutical Grade Poloxamers Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceutical Grade Poloxamers Product Location Distribution
3.4.2 Players Pharmaceutical Grade Poloxamers Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PHARMACEUTICAL GRADE POLOXAMERS BY GEOGRAPHIC REGION
4.1 World Historic Pharmaceutical Grade Poloxamers Market Size by Geographic Region (2019-2024)
4.1.1 Global Pharmaceutical Grade Poloxamers Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Pharmaceutical Grade Poloxamers Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Pharmaceutical Grade Poloxamers Market Size by Country/Region (2019-2024)
4.2.1 Global Pharmaceutical Grade Poloxamers Annual Sales by Country/Region (2019-2024)
4.2.2 Global Pharmaceutical Grade Poloxamers Annual Revenue by Country/Region (2019-2024)
4.3 Americas Pharmaceutical Grade Poloxamers Sales Growth
4.4 APAC Pharmaceutical Grade Poloxamers Sales Growth
4.5 Europe Pharmaceutical Grade Poloxamers Sales Growth
4.6 Middle East & Africa Pharmaceutical Grade Poloxamers Sales Growth
5 AMERICAS
5.1 Americas Pharmaceutical Grade Poloxamers Sales by Country
5.1.1 Americas Pharmaceutical Grade Poloxamers Sales by Country (2019-2024)
5.1.2 Americas Pharmaceutical Grade Poloxamers Revenue by Country (2019-2024)
5.2 Americas Pharmaceutical Grade Poloxamers Sales by Type (2019-2024)
5.3 Americas Pharmaceutical Grade Poloxamers Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Grade Poloxamers Sales by Region
6.1.1 APAC Pharmaceutical Grade Poloxamers Sales by Region (2019-2024)
6.1.2 APAC Pharmaceutical Grade Poloxamers Revenue by Region (2019-2024)
6.2 APAC Pharmaceutical Grade Poloxamers Sales by Type (2019-2024)
6.3 APAC Pharmaceutical Grade Poloxamers Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pharmaceutical Grade Poloxamers by Country
7.1.1 Europe Pharmaceutical Grade Poloxamers Sales by Country (2019-2024)
7.1.2 Europe Pharmaceutical Grade Poloxamers Revenue by Country (2019-2024)
7.2 Europe Pharmaceutical Grade Poloxamers Sales by Type (2019-2024)
7.3 Europe Pharmaceutical Grade Poloxamers Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical Grade Poloxamers by Country
8.1.1 Middle East & Africa Pharmaceutical Grade Poloxamers Sales by Country (2019-2024)
8.1.2 Middle East & Africa Pharmaceutical Grade Poloxamers Revenue by Country (2019-2024)
8.2 Middle East & Africa Pharmaceutical Grade Poloxamers Sales by Type (2019-2024)
8.3 Middle East & Africa Pharmaceutical Grade Poloxamers Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Grade Poloxamers
10.3 Manufacturing Process Analysis of Pharmaceutical Grade Poloxamers
10.4 Industry Chain Structure of Pharmaceutical Grade Poloxamers
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceutical Grade Poloxamers Distributors
11.3 Pharmaceutical Grade Poloxamers Customer
12 WORLD FORECAST REVIEW FOR PHARMACEUTICAL GRADE POLOXAMERS BY GEOGRAPHIC REGION
12.1 Global Pharmaceutical Grade Poloxamers Market Size Forecast by Region
12.1.1 Global Pharmaceutical Grade Poloxamers Forecast by Region (2025-2030)
12.1.2 Global Pharmaceutical Grade Poloxamers Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Pharmaceutical Grade Poloxamers Forecast by Type (2025-2030)
12.7 Global Pharmaceutical Grade Poloxamers Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 BASF
13.1.1 BASF Company Information
13.1.2 BASF Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
13.1.3 BASF Pharmaceutical Grade Poloxamers Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 BASF Main Business Overview
13.1.5 BASF Latest Developments
13.2 Croda
13.2.1 Croda Company Information
13.2.2 Croda Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
13.2.3 Croda Pharmaceutical Grade Poloxamers Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Croda Main Business Overview
13.2.5 Croda Latest Developments
13.3 Syensqo
13.3.1 Syensqo Company Information
13.3.2 Syensqo Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
13.3.3 Syensqo Pharmaceutical Grade Poloxamers Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Syensqo Main Business Overview
13.3.5 Syensqo Latest Developments
13.4 Nanjing Well Pharmaceutical
13.4.1 Nanjing Well Pharmaceutical Company Information
13.4.2 Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
13.4.3 Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamers Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Nanjing Well Pharmaceutical Main Business Overview
13.4.5 Nanjing Well Pharmaceutical Latest Developments
13.5 Hubei Hengshuo Chemical
13.5.1 Hubei Hengshuo Chemical Company Information
13.5.2 Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
13.5.3 Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamers Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Hubei Hengshuo Chemical Main Business Overview
13.5.5 Hubei Hengshuo Chemical Latest Developments
13.6 CD Formulation
13.6.1 CD Formulation Company Information
13.6.2 CD Formulation Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
13.6.3 CD Formulation Pharmaceutical Grade Poloxamers Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 CD Formulation Main Business Overview
13.6.5 CD Formulation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pharmaceutical Grade Poloxamers Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Pharmaceutical Grade Poloxamers by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Pharmaceutical Grade Poloxamers by Country/Region, 2019, 2023 & 2030
2.2 Pharmaceutical Grade Poloxamers Segment by Type
2.2.1 Poloxamer
2.2.2 Poloxamer
2.2.3 Poloxamer
2.2.4 Poloxamer
2.2.5 Others
2.3 Pharmaceutical Grade Poloxamers Sales by Type
2.3.1 Global Pharmaceutical Grade Poloxamers Sales Market Share by Type (2019-2024)
2.3.2 Global Pharmaceutical Grade Poloxamers Revenue and Market Share by Type (2019-2024)
2.3.3 Global Pharmaceutical Grade Poloxamers Sale Price by Type (2019-2024)
2.4 Pharmaceutical Grade Poloxamers Segment by Application
2.4.1 Injectable Formulation
2.4.2 Oral Formulation
2.4.3 Topical Formulation
2.5 Pharmaceutical Grade Poloxamers Sales by Application
2.5.1 Global Pharmaceutical Grade Poloxamers Sale Market Share by Application (2019-2024)
2.5.2 Global Pharmaceutical Grade Poloxamers Revenue and Market Share by Application (2019-2024)
2.5.3 Global Pharmaceutical Grade Poloxamers Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Pharmaceutical Grade Poloxamers Breakdown Data by Company
3.1.1 Global Pharmaceutical Grade Poloxamers Annual Sales by Company (2019-2024)
3.1.2 Global Pharmaceutical Grade Poloxamers Sales Market Share by Company (2019-2024)
3.2 Global Pharmaceutical Grade Poloxamers Annual Revenue by Company (2019-2024)
3.2.1 Global Pharmaceutical Grade Poloxamers Revenue by Company (2019-2024)
3.2.2 Global Pharmaceutical Grade Poloxamers Revenue Market Share by Company (2019-2024)
3.3 Global Pharmaceutical Grade Poloxamers Sale Price by Company
3.4 Key Manufacturers Pharmaceutical Grade Poloxamers Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceutical Grade Poloxamers Product Location Distribution
3.4.2 Players Pharmaceutical Grade Poloxamers Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PHARMACEUTICAL GRADE POLOXAMERS BY GEOGRAPHIC REGION
4.1 World Historic Pharmaceutical Grade Poloxamers Market Size by Geographic Region (2019-2024)
4.1.1 Global Pharmaceutical Grade Poloxamers Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Pharmaceutical Grade Poloxamers Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Pharmaceutical Grade Poloxamers Market Size by Country/Region (2019-2024)
4.2.1 Global Pharmaceutical Grade Poloxamers Annual Sales by Country/Region (2019-2024)
4.2.2 Global Pharmaceutical Grade Poloxamers Annual Revenue by Country/Region (2019-2024)
4.3 Americas Pharmaceutical Grade Poloxamers Sales Growth
4.4 APAC Pharmaceutical Grade Poloxamers Sales Growth
4.5 Europe Pharmaceutical Grade Poloxamers Sales Growth
4.6 Middle East & Africa Pharmaceutical Grade Poloxamers Sales Growth
5 AMERICAS
5.1 Americas Pharmaceutical Grade Poloxamers Sales by Country
5.1.1 Americas Pharmaceutical Grade Poloxamers Sales by Country (2019-2024)
5.1.2 Americas Pharmaceutical Grade Poloxamers Revenue by Country (2019-2024)
5.2 Americas Pharmaceutical Grade Poloxamers Sales by Type (2019-2024)
5.3 Americas Pharmaceutical Grade Poloxamers Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Grade Poloxamers Sales by Region
6.1.1 APAC Pharmaceutical Grade Poloxamers Sales by Region (2019-2024)
6.1.2 APAC Pharmaceutical Grade Poloxamers Revenue by Region (2019-2024)
6.2 APAC Pharmaceutical Grade Poloxamers Sales by Type (2019-2024)
6.3 APAC Pharmaceutical Grade Poloxamers Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pharmaceutical Grade Poloxamers by Country
7.1.1 Europe Pharmaceutical Grade Poloxamers Sales by Country (2019-2024)
7.1.2 Europe Pharmaceutical Grade Poloxamers Revenue by Country (2019-2024)
7.2 Europe Pharmaceutical Grade Poloxamers Sales by Type (2019-2024)
7.3 Europe Pharmaceutical Grade Poloxamers Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pharmaceutical Grade Poloxamers by Country
8.1.1 Middle East & Africa Pharmaceutical Grade Poloxamers Sales by Country (2019-2024)
8.1.2 Middle East & Africa Pharmaceutical Grade Poloxamers Revenue by Country (2019-2024)
8.2 Middle East & Africa Pharmaceutical Grade Poloxamers Sales by Type (2019-2024)
8.3 Middle East & Africa Pharmaceutical Grade Poloxamers Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Grade Poloxamers
10.3 Manufacturing Process Analysis of Pharmaceutical Grade Poloxamers
10.4 Industry Chain Structure of Pharmaceutical Grade Poloxamers
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceutical Grade Poloxamers Distributors
11.3 Pharmaceutical Grade Poloxamers Customer
12 WORLD FORECAST REVIEW FOR PHARMACEUTICAL GRADE POLOXAMERS BY GEOGRAPHIC REGION
12.1 Global Pharmaceutical Grade Poloxamers Market Size Forecast by Region
12.1.1 Global Pharmaceutical Grade Poloxamers Forecast by Region (2025-2030)
12.1.2 Global Pharmaceutical Grade Poloxamers Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Pharmaceutical Grade Poloxamers Forecast by Type (2025-2030)
12.7 Global Pharmaceutical Grade Poloxamers Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 BASF
13.1.1 BASF Company Information
13.1.2 BASF Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
13.1.3 BASF Pharmaceutical Grade Poloxamers Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 BASF Main Business Overview
13.1.5 BASF Latest Developments
13.2 Croda
13.2.1 Croda Company Information
13.2.2 Croda Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
13.2.3 Croda Pharmaceutical Grade Poloxamers Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Croda Main Business Overview
13.2.5 Croda Latest Developments
13.3 Syensqo
13.3.1 Syensqo Company Information
13.3.2 Syensqo Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
13.3.3 Syensqo Pharmaceutical Grade Poloxamers Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Syensqo Main Business Overview
13.3.5 Syensqo Latest Developments
13.4 Nanjing Well Pharmaceutical
13.4.1 Nanjing Well Pharmaceutical Company Information
13.4.2 Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
13.4.3 Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamers Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Nanjing Well Pharmaceutical Main Business Overview
13.4.5 Nanjing Well Pharmaceutical Latest Developments
13.5 Hubei Hengshuo Chemical
13.5.1 Hubei Hengshuo Chemical Company Information
13.5.2 Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
13.5.3 Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamers Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Hubei Hengshuo Chemical Main Business Overview
13.5.5 Hubei Hengshuo Chemical Latest Developments
13.6 CD Formulation
13.6.1 CD Formulation Company Information
13.6.2 CD Formulation Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
13.6.3 CD Formulation Pharmaceutical Grade Poloxamers Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 CD Formulation Main Business Overview
13.6.5 CD Formulation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pharmaceutical Grade Poloxamers Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Pharmaceutical Grade Poloxamers Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Poloxamer 188
Table 4. Major Players of Poloxamer 124
Table 5. Major Players of Poloxamer 407
Table 6. Major Players of Poloxamer 338
Table 7. Major Players of Others
Table 8. Global Pharmaceutical Grade Poloxamers Sales by Type (2019-2024) & (Tons)
Table 9. Global Pharmaceutical Grade Poloxamers Sales Market Share by Type (2019-2024)
Table 10. Global Pharmaceutical Grade Poloxamers Revenue by Type (2019-2024) & ($ million)
Table 11. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Type (2019-2024)
Table 12. Global Pharmaceutical Grade Poloxamers Sale Price by Type (2019-2024) & (US$/Ton)
Table 13. Global Pharmaceutical Grade Poloxamers Sale by Application (2019-2024) & (Tons)
Table 14. Global Pharmaceutical Grade Poloxamers Sale Market Share by Application (2019-2024)
Table 15. Global Pharmaceutical Grade Poloxamers Revenue by Application (2019-2024) & ($ million)
Table 16. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Application (2019-2024)
Table 17. Global Pharmaceutical Grade Poloxamers Sale Price by Application (2019-2024) & (US$/Ton)
Table 18. Global Pharmaceutical Grade Poloxamers Sales by Company (2019-2024) & (Tons)
Table 19. Global Pharmaceutical Grade Poloxamers Sales Market Share by Company (2019-2024)
Table 20. Global Pharmaceutical Grade Poloxamers Revenue by Company (2019-2024) & ($ millions)
Table 21. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Company (2019-2024)
Table 22. Global Pharmaceutical Grade Poloxamers Sale Price by Company (2019-2024) & (US$/Ton)
Table 23. Key Manufacturers Pharmaceutical Grade Poloxamers Producing Area Distribution and Sales Area
Table 24. Players Pharmaceutical Grade Poloxamers Products Offered
Table 25. Pharmaceutical Grade Poloxamers Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Pharmaceutical Grade Poloxamers Sales by Geographic Region (2019-2024) & (Tons)
Table 29. Global Pharmaceutical Grade Poloxamers Sales Market Share Geographic Region (2019-2024)
Table 30. Global Pharmaceutical Grade Poloxamers Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Pharmaceutical Grade Poloxamers Sales by Country/Region (2019-2024) & (Tons)
Table 33. Global Pharmaceutical Grade Poloxamers Sales Market Share by Country/Region (2019-2024)
Table 34. Global Pharmaceutical Grade Poloxamers Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Pharmaceutical Grade Poloxamers Sales by Country (2019-2024) & (Tons)
Table 37. Americas Pharmaceutical Grade Poloxamers Sales Market Share by Country (2019-2024)
Table 38. Americas Pharmaceutical Grade Poloxamers Revenue by Country (2019-2024) & ($ millions)
Table 39. Americas Pharmaceutical Grade Poloxamers Sales by Type (2019-2024) & (Tons)
Table 40. Americas Pharmaceutical Grade Poloxamers Sales by Application (2019-2024) & (Tons)
Table 41. APAC Pharmaceutical Grade Poloxamers Sales by Region (2019-2024) & (Tons)
Table 42. APAC Pharmaceutical Grade Poloxamers Sales Market Share by Region (2019-2024)
Table 43. APAC Pharmaceutical Grade Poloxamers Revenue by Region (2019-2024) & ($ millions)
Table 44. APAC Pharmaceutical Grade Poloxamers Sales by Type (2019-2024) & (Tons)
Table 45. APAC Pharmaceutical Grade Poloxamers Sales by Application (2019-2024) & (Tons)
Table 46. Europe Pharmaceutical Grade Poloxamers Sales by Country (2019-2024) & (Tons)
Table 47. Europe Pharmaceutical Grade Poloxamers Revenue by Country (2019-2024) & ($ millions)
Table 48. Europe Pharmaceutical Grade Poloxamers Sales by Type (2019-2024) & (Tons)
Table 49. Europe Pharmaceutical Grade Poloxamers Sales by Application (2019-2024) & (Tons)
Table 50. Middle East & Africa Pharmaceutical Grade Poloxamers Sales by Country (2019-2024) & (Tons)
Table 51. Middle East & Africa Pharmaceutical Grade Poloxamers Revenue Market Share by Country (2019-2024)
Table 52. Middle East & Africa Pharmaceutical Grade Poloxamers Sales by Type (2019-2024) & (Tons)
Table 53. Middle East & Africa Pharmaceutical Grade Poloxamers Sales by Application (2019-2024) & (Tons)
Table 54. Key Market Drivers & Growth Opportunities of Pharmaceutical Grade Poloxamers
Table 55. Key Market Challenges & Risks of Pharmaceutical Grade Poloxamers
Table 56. Key Industry Trends of Pharmaceutical Grade Poloxamers
Table 57. Pharmaceutical Grade Poloxamers Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Pharmaceutical Grade Poloxamers Distributors List
Table 60. Pharmaceutical Grade Poloxamers Customer List
Table 61. Global Pharmaceutical Grade Poloxamers Sales Forecast by Region (2025-2030) & (Tons)
Table 62. Global Pharmaceutical Grade Poloxamers Revenue Forecast by Region (2025-2030) & ($ millions)
Table 63. Americas Pharmaceutical Grade Poloxamers Sales Forecast by Country (2025-2030) & (Tons)
Table 64. Americas Pharmaceutical Grade Poloxamers Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 65. APAC Pharmaceutical Grade Poloxamers Sales Forecast by Region (2025-2030) & (Tons)
Table 66. APAC Pharmaceutical Grade Poloxamers Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Europe Pharmaceutical Grade Poloxamers Sales Forecast by Country (2025-2030) & (Tons)
Table 68. Europe Pharmaceutical Grade Poloxamers Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Middle East & Africa Pharmaceutical Grade Poloxamers Sales Forecast by Country (2025-2030) & (Tons)
Table 70. Middle East & Africa Pharmaceutical Grade Poloxamers Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. Global Pharmaceutical Grade Poloxamers Sales Forecast by Type (2025-2030) & (Tons)
Table 72. Global Pharmaceutical Grade Poloxamers Revenue Forecast by Type (2025-2030) & ($ millions)
Table 73. Global Pharmaceutical Grade Poloxamers Sales Forecast by Application (2025-2030) & (Tons)
Table 74. Global Pharmaceutical Grade Poloxamers Revenue Forecast by Application (2025-2030) & ($ millions)
Table 75. BASF Basic Information, Pharmaceutical Grade Poloxamers Manufacturing Base, Sales Area and Its Competitors
Table 76. BASF Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
Table 77. BASF Pharmaceutical Grade Poloxamers Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 78. BASF Main Business
Table 79. BASF Latest Developments
Table 80. Croda Basic Information, Pharmaceutical Grade Poloxamers Manufacturing Base, Sales Area and Its Competitors
Table 81. Croda Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
Table 82. Croda Pharmaceutical Grade Poloxamers Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 83. Croda Main Business
Table 84. Croda Latest Developments
Table 85. Syensqo Basic Information, Pharmaceutical Grade Poloxamers Manufacturing Base, Sales Area and Its Competitors
Table 86. Syensqo Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
Table 87. Syensqo Pharmaceutical Grade Poloxamers Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 88. Syensqo Main Business
Table 89. Syensqo Latest Developments
Table 90. Nanjing Well Pharmaceutical Basic Information, Pharmaceutical Grade Poloxamers Manufacturing Base, Sales Area and Its Competitors
Table 91. Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
Table 92. Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamers Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 93. Nanjing Well Pharmaceutical Main Business
Table 94. Nanjing Well Pharmaceutical Latest Developments
Table 95. Hubei Hengshuo Chemical Basic Information, Pharmaceutical Grade Poloxamers Manufacturing Base, Sales Area and Its Competitors
Table 96. Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
Table 97. Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamers Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 98. Hubei Hengshuo Chemical Main Business
Table 99. Hubei Hengshuo Chemical Latest Developments
Table 100. CD Formulation Basic Information, Pharmaceutical Grade Poloxamers Manufacturing Base, Sales Area and Its Competitors
Table 101. CD Formulation Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
Table 102. CD Formulation Pharmaceutical Grade Poloxamers Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 103. CD Formulation Main Business
Table 104. CD Formulation Latest Developments
Table 1. Pharmaceutical Grade Poloxamers Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Pharmaceutical Grade Poloxamers Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Poloxamer 188
Table 4. Major Players of Poloxamer 124
Table 5. Major Players of Poloxamer 407
Table 6. Major Players of Poloxamer 338
Table 7. Major Players of Others
Table 8. Global Pharmaceutical Grade Poloxamers Sales by Type (2019-2024) & (Tons)
Table 9. Global Pharmaceutical Grade Poloxamers Sales Market Share by Type (2019-2024)
Table 10. Global Pharmaceutical Grade Poloxamers Revenue by Type (2019-2024) & ($ million)
Table 11. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Type (2019-2024)
Table 12. Global Pharmaceutical Grade Poloxamers Sale Price by Type (2019-2024) & (US$/Ton)
Table 13. Global Pharmaceutical Grade Poloxamers Sale by Application (2019-2024) & (Tons)
Table 14. Global Pharmaceutical Grade Poloxamers Sale Market Share by Application (2019-2024)
Table 15. Global Pharmaceutical Grade Poloxamers Revenue by Application (2019-2024) & ($ million)
Table 16. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Application (2019-2024)
Table 17. Global Pharmaceutical Grade Poloxamers Sale Price by Application (2019-2024) & (US$/Ton)
Table 18. Global Pharmaceutical Grade Poloxamers Sales by Company (2019-2024) & (Tons)
Table 19. Global Pharmaceutical Grade Poloxamers Sales Market Share by Company (2019-2024)
Table 20. Global Pharmaceutical Grade Poloxamers Revenue by Company (2019-2024) & ($ millions)
Table 21. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Company (2019-2024)
Table 22. Global Pharmaceutical Grade Poloxamers Sale Price by Company (2019-2024) & (US$/Ton)
Table 23. Key Manufacturers Pharmaceutical Grade Poloxamers Producing Area Distribution and Sales Area
Table 24. Players Pharmaceutical Grade Poloxamers Products Offered
Table 25. Pharmaceutical Grade Poloxamers Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Pharmaceutical Grade Poloxamers Sales by Geographic Region (2019-2024) & (Tons)
Table 29. Global Pharmaceutical Grade Poloxamers Sales Market Share Geographic Region (2019-2024)
Table 30. Global Pharmaceutical Grade Poloxamers Revenue by Geographic Region (2019-2024) & ($ millions)
Table 31. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Geographic Region (2019-2024)
Table 32. Global Pharmaceutical Grade Poloxamers Sales by Country/Region (2019-2024) & (Tons)
Table 33. Global Pharmaceutical Grade Poloxamers Sales Market Share by Country/Region (2019-2024)
Table 34. Global Pharmaceutical Grade Poloxamers Revenue by Country/Region (2019-2024) & ($ millions)
Table 35. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Country/Region (2019-2024)
Table 36. Americas Pharmaceutical Grade Poloxamers Sales by Country (2019-2024) & (Tons)
Table 37. Americas Pharmaceutical Grade Poloxamers Sales Market Share by Country (2019-2024)
Table 38. Americas Pharmaceutical Grade Poloxamers Revenue by Country (2019-2024) & ($ millions)
Table 39. Americas Pharmaceutical Grade Poloxamers Sales by Type (2019-2024) & (Tons)
Table 40. Americas Pharmaceutical Grade Poloxamers Sales by Application (2019-2024) & (Tons)
Table 41. APAC Pharmaceutical Grade Poloxamers Sales by Region (2019-2024) & (Tons)
Table 42. APAC Pharmaceutical Grade Poloxamers Sales Market Share by Region (2019-2024)
Table 43. APAC Pharmaceutical Grade Poloxamers Revenue by Region (2019-2024) & ($ millions)
Table 44. APAC Pharmaceutical Grade Poloxamers Sales by Type (2019-2024) & (Tons)
Table 45. APAC Pharmaceutical Grade Poloxamers Sales by Application (2019-2024) & (Tons)
Table 46. Europe Pharmaceutical Grade Poloxamers Sales by Country (2019-2024) & (Tons)
Table 47. Europe Pharmaceutical Grade Poloxamers Revenue by Country (2019-2024) & ($ millions)
Table 48. Europe Pharmaceutical Grade Poloxamers Sales by Type (2019-2024) & (Tons)
Table 49. Europe Pharmaceutical Grade Poloxamers Sales by Application (2019-2024) & (Tons)
Table 50. Middle East & Africa Pharmaceutical Grade Poloxamers Sales by Country (2019-2024) & (Tons)
Table 51. Middle East & Africa Pharmaceutical Grade Poloxamers Revenue Market Share by Country (2019-2024)
Table 52. Middle East & Africa Pharmaceutical Grade Poloxamers Sales by Type (2019-2024) & (Tons)
Table 53. Middle East & Africa Pharmaceutical Grade Poloxamers Sales by Application (2019-2024) & (Tons)
Table 54. Key Market Drivers & Growth Opportunities of Pharmaceutical Grade Poloxamers
Table 55. Key Market Challenges & Risks of Pharmaceutical Grade Poloxamers
Table 56. Key Industry Trends of Pharmaceutical Grade Poloxamers
Table 57. Pharmaceutical Grade Poloxamers Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Pharmaceutical Grade Poloxamers Distributors List
Table 60. Pharmaceutical Grade Poloxamers Customer List
Table 61. Global Pharmaceutical Grade Poloxamers Sales Forecast by Region (2025-2030) & (Tons)
Table 62. Global Pharmaceutical Grade Poloxamers Revenue Forecast by Region (2025-2030) & ($ millions)
Table 63. Americas Pharmaceutical Grade Poloxamers Sales Forecast by Country (2025-2030) & (Tons)
Table 64. Americas Pharmaceutical Grade Poloxamers Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 65. APAC Pharmaceutical Grade Poloxamers Sales Forecast by Region (2025-2030) & (Tons)
Table 66. APAC Pharmaceutical Grade Poloxamers Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 67. Europe Pharmaceutical Grade Poloxamers Sales Forecast by Country (2025-2030) & (Tons)
Table 68. Europe Pharmaceutical Grade Poloxamers Revenue Forecast by Country (2025-2030) & ($ millions)
Table 69. Middle East & Africa Pharmaceutical Grade Poloxamers Sales Forecast by Country (2025-2030) & (Tons)
Table 70. Middle East & Africa Pharmaceutical Grade Poloxamers Revenue Forecast by Country (2025-2030) & ($ millions)
Table 71. Global Pharmaceutical Grade Poloxamers Sales Forecast by Type (2025-2030) & (Tons)
Table 72. Global Pharmaceutical Grade Poloxamers Revenue Forecast by Type (2025-2030) & ($ millions)
Table 73. Global Pharmaceutical Grade Poloxamers Sales Forecast by Application (2025-2030) & (Tons)
Table 74. Global Pharmaceutical Grade Poloxamers Revenue Forecast by Application (2025-2030) & ($ millions)
Table 75. BASF Basic Information, Pharmaceutical Grade Poloxamers Manufacturing Base, Sales Area and Its Competitors
Table 76. BASF Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
Table 77. BASF Pharmaceutical Grade Poloxamers Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 78. BASF Main Business
Table 79. BASF Latest Developments
Table 80. Croda Basic Information, Pharmaceutical Grade Poloxamers Manufacturing Base, Sales Area and Its Competitors
Table 81. Croda Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
Table 82. Croda Pharmaceutical Grade Poloxamers Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 83. Croda Main Business
Table 84. Croda Latest Developments
Table 85. Syensqo Basic Information, Pharmaceutical Grade Poloxamers Manufacturing Base, Sales Area and Its Competitors
Table 86. Syensqo Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
Table 87. Syensqo Pharmaceutical Grade Poloxamers Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 88. Syensqo Main Business
Table 89. Syensqo Latest Developments
Table 90. Nanjing Well Pharmaceutical Basic Information, Pharmaceutical Grade Poloxamers Manufacturing Base, Sales Area and Its Competitors
Table 91. Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
Table 92. Nanjing Well Pharmaceutical Pharmaceutical Grade Poloxamers Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 93. Nanjing Well Pharmaceutical Main Business
Table 94. Nanjing Well Pharmaceutical Latest Developments
Table 95. Hubei Hengshuo Chemical Basic Information, Pharmaceutical Grade Poloxamers Manufacturing Base, Sales Area and Its Competitors
Table 96. Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
Table 97. Hubei Hengshuo Chemical Pharmaceutical Grade Poloxamers Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 98. Hubei Hengshuo Chemical Main Business
Table 99. Hubei Hengshuo Chemical Latest Developments
Table 100. CD Formulation Basic Information, Pharmaceutical Grade Poloxamers Manufacturing Base, Sales Area and Its Competitors
Table 101. CD Formulation Pharmaceutical Grade Poloxamers Product Portfolios and Specifications
Table 102. CD Formulation Pharmaceutical Grade Poloxamers Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 103. CD Formulation Main Business
Table 104. CD Formulation Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pharmaceutical Grade Poloxamers
Figure 2. Pharmaceutical Grade Poloxamers Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pharmaceutical Grade Poloxamers Sales Growth Rate 2019-2030 (Tons)
Figure 7. Global Pharmaceutical Grade Poloxamers Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Pharmaceutical Grade Poloxamers Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Pharmaceutical Grade Poloxamers Sales Market Share by Country/Region (2023)
Figure 10. Pharmaceutical Grade Poloxamers Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Poloxamer 188
Figure 12. Product Picture of Poloxamer 124
Figure 13. Product Picture of Poloxamer 407
Figure 14. Product Picture of Poloxamer 338
Figure 15. Product Picture of Others
Figure 16. Global Pharmaceutical Grade Poloxamers Sales Market Share by Type in 2023
Figure 17. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Type (2019-2024)
Figure 18. Pharmaceutical Grade Poloxamers Consumed in Injectable Formulation
Figure 19. Global Pharmaceutical Grade Poloxamers Market: Injectable Formulation (2019-2024) & (Tons)
Figure 20. Pharmaceutical Grade Poloxamers Consumed in Oral Formulation
Figure 21. Global Pharmaceutical Grade Poloxamers Market: Oral Formulation (2019-2024) & (Tons)
Figure 22. Pharmaceutical Grade Poloxamers Consumed in Topical Formulation
Figure 23. Global Pharmaceutical Grade Poloxamers Market: Topical Formulation (2019-2024) & (Tons)
Figure 24. Global Pharmaceutical Grade Poloxamers Sale Market Share by Application (2023)
Figure 25. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Application in 2023
Figure 26. Pharmaceutical Grade Poloxamers Sales by Company in 2023 (Tons)
Figure 27. Global Pharmaceutical Grade Poloxamers Sales Market Share by Company in 2023
Figure 28. Pharmaceutical Grade Poloxamers Revenue by Company in 2023 ($ millions)
Figure 29. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Company in 2023
Figure 30. Global Pharmaceutical Grade Poloxamers Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Pharmaceutical Grade Poloxamers Sales 2019-2024 (Tons)
Figure 33. Americas Pharmaceutical Grade Poloxamers Revenue 2019-2024 ($ millions)
Figure 34. APAC Pharmaceutical Grade Poloxamers Sales 2019-2024 (Tons)
Figure 35. APAC Pharmaceutical Grade Poloxamers Revenue 2019-2024 ($ millions)
Figure 36. Europe Pharmaceutical Grade Poloxamers Sales 2019-2024 (Tons)
Figure 37. Europe Pharmaceutical Grade Poloxamers Revenue 2019-2024 ($ millions)
Figure 38. Middle East & Africa Pharmaceutical Grade Poloxamers Sales 2019-2024 (Tons)
Figure 39. Middle East & Africa Pharmaceutical Grade Poloxamers Revenue 2019-2024 ($ millions)
Figure 40. Americas Pharmaceutical Grade Poloxamers Sales Market Share by Country in 2023
Figure 41. Americas Pharmaceutical Grade Poloxamers Revenue Market Share by Country (2019-2024)
Figure 42. Americas Pharmaceutical Grade Poloxamers Sales Market Share by Type (2019-2024)
Figure 43. Americas Pharmaceutical Grade Poloxamers Sales Market Share by Application (2019-2024)
Figure 44. United States Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 45. Canada Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 46. Mexico Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 47. Brazil Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 48. APAC Pharmaceutical Grade Poloxamers Sales Market Share by Region in 2023
Figure 49. APAC Pharmaceutical Grade Poloxamers Revenue Market Share by Region (2019-2024)
Figure 50. APAC Pharmaceutical Grade Poloxamers Sales Market Share by Type (2019-2024)
Figure 51. APAC Pharmaceutical Grade Poloxamers Sales Market Share by Application (2019-2024)
Figure 52. China Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 53. Japan Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 54. South Korea Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 55. Southeast Asia Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 56. India Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 57. Australia Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 58. China Taiwan Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 59. Europe Pharmaceutical Grade Poloxamers Sales Market Share by Country in 2023
Figure 60. Europe Pharmaceutical Grade Poloxamers Revenue Market Share by Country (2019-2024)
Figure 61. Europe Pharmaceutical Grade Poloxamers Sales Market Share by Type (2019-2024)
Figure 62. Europe Pharmaceutical Grade Poloxamers Sales Market Share by Application (2019-2024)
Figure 63. Germany Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 64. France Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 65. UK Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 66. Italy Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 67. Russia Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 68. Middle East & Africa Pharmaceutical Grade Poloxamers Sales Market Share by Country (2019-2024)
Figure 69. Middle East & Africa Pharmaceutical Grade Poloxamers Sales Market Share by Type (2019-2024)
Figure 70. Middle East & Africa Pharmaceutical Grade Poloxamers Sales Market Share by Application (2019-2024)
Figure 71. Egypt Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 72. South Africa Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 73. Israel Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 74. Turkey Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 75. GCC Countries Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Pharmaceutical Grade Poloxamers in 2023
Figure 77. Manufacturing Process Analysis of Pharmaceutical Grade Poloxamers
Figure 78. Industry Chain Structure of Pharmaceutical Grade Poloxamers
Figure 79. Channels of Distribution
Figure 80. Global Pharmaceutical Grade Poloxamers Sales Market Forecast by Region (2025-2030)
Figure 81. Global Pharmaceutical Grade Poloxamers Revenue Market Share Forecast by Region (2025-2030)
Figure 82. Global Pharmaceutical Grade Poloxamers Sales Market Share Forecast by Type (2025-2030)
Figure 83. Global Pharmaceutical Grade Poloxamers Revenue Market Share Forecast by Type (2025-2030)
Figure 84. Global Pharmaceutical Grade Poloxamers Sales Market Share Forecast by Application (2025-2030)
Figure 85. Global Pharmaceutical Grade Poloxamers Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Pharmaceutical Grade Poloxamers
Figure 2. Pharmaceutical Grade Poloxamers Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pharmaceutical Grade Poloxamers Sales Growth Rate 2019-2030 (Tons)
Figure 7. Global Pharmaceutical Grade Poloxamers Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Pharmaceutical Grade Poloxamers Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Pharmaceutical Grade Poloxamers Sales Market Share by Country/Region (2023)
Figure 10. Pharmaceutical Grade Poloxamers Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Poloxamer 188
Figure 12. Product Picture of Poloxamer 124
Figure 13. Product Picture of Poloxamer 407
Figure 14. Product Picture of Poloxamer 338
Figure 15. Product Picture of Others
Figure 16. Global Pharmaceutical Grade Poloxamers Sales Market Share by Type in 2023
Figure 17. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Type (2019-2024)
Figure 18. Pharmaceutical Grade Poloxamers Consumed in Injectable Formulation
Figure 19. Global Pharmaceutical Grade Poloxamers Market: Injectable Formulation (2019-2024) & (Tons)
Figure 20. Pharmaceutical Grade Poloxamers Consumed in Oral Formulation
Figure 21. Global Pharmaceutical Grade Poloxamers Market: Oral Formulation (2019-2024) & (Tons)
Figure 22. Pharmaceutical Grade Poloxamers Consumed in Topical Formulation
Figure 23. Global Pharmaceutical Grade Poloxamers Market: Topical Formulation (2019-2024) & (Tons)
Figure 24. Global Pharmaceutical Grade Poloxamers Sale Market Share by Application (2023)
Figure 25. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Application in 2023
Figure 26. Pharmaceutical Grade Poloxamers Sales by Company in 2023 (Tons)
Figure 27. Global Pharmaceutical Grade Poloxamers Sales Market Share by Company in 2023
Figure 28. Pharmaceutical Grade Poloxamers Revenue by Company in 2023 ($ millions)
Figure 29. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Company in 2023
Figure 30. Global Pharmaceutical Grade Poloxamers Sales Market Share by Geographic Region (2019-2024)
Figure 31. Global Pharmaceutical Grade Poloxamers Revenue Market Share by Geographic Region in 2023
Figure 32. Americas Pharmaceutical Grade Poloxamers Sales 2019-2024 (Tons)
Figure 33. Americas Pharmaceutical Grade Poloxamers Revenue 2019-2024 ($ millions)
Figure 34. APAC Pharmaceutical Grade Poloxamers Sales 2019-2024 (Tons)
Figure 35. APAC Pharmaceutical Grade Poloxamers Revenue 2019-2024 ($ millions)
Figure 36. Europe Pharmaceutical Grade Poloxamers Sales 2019-2024 (Tons)
Figure 37. Europe Pharmaceutical Grade Poloxamers Revenue 2019-2024 ($ millions)
Figure 38. Middle East & Africa Pharmaceutical Grade Poloxamers Sales 2019-2024 (Tons)
Figure 39. Middle East & Africa Pharmaceutical Grade Poloxamers Revenue 2019-2024 ($ millions)
Figure 40. Americas Pharmaceutical Grade Poloxamers Sales Market Share by Country in 2023
Figure 41. Americas Pharmaceutical Grade Poloxamers Revenue Market Share by Country (2019-2024)
Figure 42. Americas Pharmaceutical Grade Poloxamers Sales Market Share by Type (2019-2024)
Figure 43. Americas Pharmaceutical Grade Poloxamers Sales Market Share by Application (2019-2024)
Figure 44. United States Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 45. Canada Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 46. Mexico Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 47. Brazil Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 48. APAC Pharmaceutical Grade Poloxamers Sales Market Share by Region in 2023
Figure 49. APAC Pharmaceutical Grade Poloxamers Revenue Market Share by Region (2019-2024)
Figure 50. APAC Pharmaceutical Grade Poloxamers Sales Market Share by Type (2019-2024)
Figure 51. APAC Pharmaceutical Grade Poloxamers Sales Market Share by Application (2019-2024)
Figure 52. China Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 53. Japan Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 54. South Korea Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 55. Southeast Asia Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 56. India Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 57. Australia Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 58. China Taiwan Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 59. Europe Pharmaceutical Grade Poloxamers Sales Market Share by Country in 2023
Figure 60. Europe Pharmaceutical Grade Poloxamers Revenue Market Share by Country (2019-2024)
Figure 61. Europe Pharmaceutical Grade Poloxamers Sales Market Share by Type (2019-2024)
Figure 62. Europe Pharmaceutical Grade Poloxamers Sales Market Share by Application (2019-2024)
Figure 63. Germany Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 64. France Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 65. UK Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 66. Italy Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 67. Russia Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 68. Middle East & Africa Pharmaceutical Grade Poloxamers Sales Market Share by Country (2019-2024)
Figure 69. Middle East & Africa Pharmaceutical Grade Poloxamers Sales Market Share by Type (2019-2024)
Figure 70. Middle East & Africa Pharmaceutical Grade Poloxamers Sales Market Share by Application (2019-2024)
Figure 71. Egypt Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 72. South Africa Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 73. Israel Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 74. Turkey Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 75. GCC Countries Pharmaceutical Grade Poloxamers Revenue Growth 2019-2024 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Pharmaceutical Grade Poloxamers in 2023
Figure 77. Manufacturing Process Analysis of Pharmaceutical Grade Poloxamers
Figure 78. Industry Chain Structure of Pharmaceutical Grade Poloxamers
Figure 79. Channels of Distribution
Figure 80. Global Pharmaceutical Grade Poloxamers Sales Market Forecast by Region (2025-2030)
Figure 81. Global Pharmaceutical Grade Poloxamers Revenue Market Share Forecast by Region (2025-2030)
Figure 82. Global Pharmaceutical Grade Poloxamers Sales Market Share Forecast by Type (2025-2030)
Figure 83. Global Pharmaceutical Grade Poloxamers Revenue Market Share Forecast by Type (2025-2030)
Figure 84. Global Pharmaceutical Grade Poloxamers Sales Market Share Forecast by Application (2025-2030)
Figure 85. Global Pharmaceutical Grade Poloxamers Revenue Market Share Forecast by Application (2025-2030)
